$UNH

How many employees does UnitedHealth have in 2026? Locations & layoffs explained

UnitedHealth Group, a Dow Jones component, reported over 390,000 employees globally as of 2025, with 90,000 affiliated physicians. In 2026, it conducted layoffs, reduced clinics, and adjusted its revenue outlook to $439B, down 2% from 2025. Q2 earnings guidance was raised to $19.50-$20 per share, citing cost management and AI. CEO Brian Thompson was killed in 2024, sparking public backlash against the company.

Original reporting
Published Sep 4, 2026, 1:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 2:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
How many employees does UnitedHealth have in 2026? Locations & layoffs explained — source image
Decision brief

The 30-second read

$UNHBullishMed
01

Why it matters

The guidance upgrade signals a turnaround after a prior revenue outlook cut, suggesting improved operational efficiency.

02

Market read

UNH's guidance update is a material corporate development for a mega‑cap health insurer, likely influencing its stock and sector peers.

03

What to watch

Potential impact of ongoing layoffs and cost‑cutting on employee morale and service quality.

Relevance 7/10Novelty 6/10Timing: July 2026 guidance raise

Background

UNH is the largest U.S. health insurer and a Dow component, with recent revenue pressure and a 38% share decline in 2025.

Company-level read

Ticker impact

$UNHBullishMedium confidence
Context

UNH raised its 2026 adjusted earnings guidance to $19.50‑$20 per share after earlier cutting outlook, indicating improved profitability.

Expected impact

Modest upside as investors reprice earnings expectations.

Evidence & confidence

Guidance upgrades are material for a large cap health insurer; the new range is a fresh data point not previously disclosed.

Market effects

Higher earnings outlook may lift broader health‑care and insurance sector sentiment.

Positive for U.S. markets where UNH is a Dow component.

Limited; primarily U.S. investors focus.

Counterpoint

The guidance raise could be offset by lingering concerns over Medicaid shrinkage and regulatory pressures.

Key entities

  • Wayne DeVeydt

    CFO who announced the earnings guidance raise.

Related articles

$UNHMed

UnitedHealth’s Policy Change Opens a New Chapter for its Insurance Business

UnitedHealthcare, a unit of UnitedHealth Group (UNH), will remove prior authorization for 30% of healthcare services by 2026, starting October 1. The change covers various services and plans, aiming to reduce administrative burdens and improve provider and member experiences. The company also plans to accelerate payments for rural hospitals. The move may improve relationships but could increase healthcare utilization and costs, according to the company.

$CVXMedAI 8/10

Dow Falls 419 Points as Bond Yields Rise: Stock Market Today

The Dow fell 419 points as bond yields rose, driven by Middle East tensions and rising oil prices. Energy stocks like Chevron (CVX) gained, while tech stocks declined. Apple (AAPL) rose 2.6% under new leadership. Palo Alto Networks (PANW) dropped 5.2% ahead of earnings. Novartis (NVS) surged 6.0% on positive drug trial results. The 10-year Treasury yield hit 4.792%.

$UNHHighAI 8/10

How Is UnitedHealth Group's Stock Performance Compared to Other Healthcare Plan Stocks?

UnitedHealth Group (UNH), a $352.7B healthcare company, has underperformed the S&P Health Care Services ETF (XHS) over the past three and 12 months. UNH stock is down 14.9% from its 52-week high but up 19% YTD. Q2 2026 earnings beat estimates, with adjusted EPS of $6.38 and revenue of $112B. UNH raised its 2026 EPS outlook to $19.50-$20. Analysts rate UNH a 'Strong Buy' with a mean price target of $480.81, 22.4% above current levels.

$UNHMed

Bernstein Issues a Buy Rating on UnitedHealth (UNH)

Bernstein analyst Lance Wilkes initiated coverage on UnitedHealth (UNH) with a Buy rating and a $512 price target. The company reported Q2 revenue of $112.03B and net profit of $5.48B, up from $111.62B and $3.41B last year. Analyst consensus is Strong Buy with a $481.67 target. Insider sentiment is negative, with recent sales by executives.

$UNHMedAI 9/10

Maryland Sues UnitedHealth, Optum For $380 Million Over Medicaid System Crash

Maryland sued UnitedHealth Group (UNH) and its subsidiary Optum for $380M, alleging their defective Medicaid system crashed in 2020, causing $126.9M in contract losses and operational disruptions. The state claims the system failed to process claims accurately, leading to fraud and financial strain. The lawsuit seeks triple damages for alleged False Claims Act violations and other breaches.

$UNHMed

Can a $68 Billion Payout Save UNH Stock?

UnitedHealth Group (UNH) returned $68B to shareholders over five years via dividends and buybacks, but its stock gained only 4.9%, underperforming the S&P 500. The company faces cost pressures in its commercial business, while Medicare and Optum segments perform well. Management expects long-term growth of 13-16% and raised 2026 earnings guidance to $19.50-$20 per share.